Mostrar el registro sencillo del documento

dc.creatorDepeursinge, Adrien
dc.creatorRacoceanu, Daniel
dc.creatorIavindrasana, Jimison
dc.creatorCohen, Gilles
dc.creatorPlaton, Alexandra
dc.creatorPoletti, Pierre-Alexandre
dc.creatorMuller, Henning
dc.date.accessioned2020-09-07T15:56:11Z
dc.date.available2020-09-07T15:56:11Z
dc.date.created2020-07-22
dc.identifier.issn0914-5087spa
dc.identifier.otherhttps://www.sciencedirect.com/science/article/pii/S0914508720302549spa
dc.identifier.urihttp://hdl.handle.net/20.500.12010/12829
dc.format.extent6 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.language.isoengspa
dc.publisherJournal of Cardiologyspa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCOVID-19spa
dc.titleCOVID-19 and cardiovascular diseasesspa
dc.type.localArtículospa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.rights.accessrightsinfo:eu-repo/semantics/embargoedAccessspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.rights.localAcceso restringidospa
dc.subject.keywordCardiovascular diseasesspa
dc.subject.keywordRenin-angiotensin-aldosterone system inhibitorsspa
dc.subject.keywordCoagulationspa
dc.subject.keywordElectrocardiographyspa
dc.identifier.doihttps://doi.org/10.1016/j.jjcc.2020.07.013spa
dc.description.abstractenglishInfection by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is responsible for the second pandemic of the XXI century after influenza A in 2009. As of mid-June 2020, more than 4,40,000 fatal cases of SARS-CoV-2-related disease (COVID-19) have occurred worldwide. Besides its prominent expression at the level of the respiratory apparatus, COVID-19 is also characterized by a substantial degree of cardiovascular involvement, both in terms of deterioration of pre-existing conditions, and as the effect of inflammation-facilitated acute events. They include ischemic/inflammatory heart disease, ventricular arrhythmias, conduction disturbances, thrombotic events at the level of the lungs, and systemic activation of the coagulation cascade, configuring the scenario of disseminated intravascular coagulation. Herein, we summarize the main COVID-19 features of relevance for the clinicians in the cardiovascular field. The rationale, concerns, and possible side effects of specific therapeutic measures, including anticoagulants, renin-angiotensin-aldosterone system inhibitors, and anti-inflammatory/antiviral medications applied to the treatment of COVID-19 are also discussed.spa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa


Archivos en el documento

ArchivosTamañoFormatoVer

No hay archivos asociados a este documento.

Este documento aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del documento